PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer

As wider insights are gained on the molecular landscape of triple-negative breast cancer (TNBC), novel targeted therapeutic strategies might become an option in this setting as well. Activating mutations of PIK3CA represent the second most common alteration in TNBC after the TP53 mutation, with a pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Amato, Ottavia, Buisseret, Laurence, Gebhart, Géraldine, Plouznikoff, Nicolas, Larsimont, Denis, Awada, Ahmad, Piccart, Martine, Aftimos, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2023
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240844/
https://www.ncbi.nlm.nih.gov/pubmed/36863843
http://dx.doi.org/10.1101/mcs.a006255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240844/
https://www.ncbi.nlm.nih.gov/pubmed/36863843
http://dx.doi.org/10.1101/mcs.a006255

Ejemplares similares